Reactive Arthritis Clinical Trials

Find Reactive Arthritis Clinical Trials Near You

Advancing the Understanding of Pain Mechanisms in Inflammatory Arthritis Towards Precision Pain Management

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• All patients who initiate or switch biological or targeted synthetic DMARDs

Locations
Other Locations
Norway
Diakonhjemmet Hospital
RECRUITING
Oslo
Contact Information
Primary
Ida K Haugen, MD PhD
ida.k.haugen@gmail.com
+47 95859884
Time Frame
Start Date: 2025-11-11
Estimated Completion Date: 2027-11
Participants
Target number of participants: 350
Treatments
Patients who initiate or switch biological or targeted synthetic DMARD
All patients initiate or switch biological or targeted synthetic DMARD
Sponsors
Collaborators: University of Oslo
Leads: Diakonhjemmet Hospital

This content was sourced from clinicaltrials.gov